[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches

Evelyn E. C. de Jong, Wouter van Elmpt, Ralph T. H. Leijenaar, Otto S. Hoekstra, Harry J. M. Groen, Egbert F. Smit, Ronald Boellaard, Vincent van der Noort, Esther G. C. Troost, Philippe Lambin, Anne-Marie C. Dingemans

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)8-16
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume44
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • Bevacizumab
  • Nitroglycerin
  • Response assessment
  • Stage IV NSCLC
  • [18F]FDG PET/CT

Cite this